Online cardiac rehabilitation with mindfulness for people with coronary heart disease
Official title: Effect of Mindfulness-based eHealth Cardiac Rehabilitation on Psychological Wellbeing and Risk Factor Management of Patients With Coronary Heart Disease: A Randomized Controlled Trial
Run by Tung Wah College · NCT07109752 · Data updated 2026-11-12
This project will test whether an online cardiac rehab program that includes mindfulness can reduce stress and improve health in people with coronary heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | Tung Wah College Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | July 20, 2024 |
| Main results expected | January 30, 2026 |
| Study ends | January 30, 2026 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT07109752 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) diagnosed with coronary heart disease within the past 6 months, discharged to home on a stable medication regimen, reporting moderate-to-high stress (single-item score 3–5), able to read and speak Chinese, and able to use a smartphone or computer at home are ideal candidates.
✕Probably not a fit
Patients with acute psychotic disorders, life-limiting conditions, medical contraindications to physical activity, or significant hearing, visual, or mobility impairments — and those unable to use the internet or who do not read/speak Chinese — are unlikely to benefit from this online program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-blinded, two-group randomized controlled project lasting 12 weeks that compares an online cardiac rehabilitation program with mindfulness to a control condition. Participants complete questionnaires and wear activity monitors at baseline, 6 weeks, and 12 weeks, and a subset will take part in a 30–40 minute interview after the trial. Those in the intervention group receive a face-to-face onboarding session, access to a CR website and activity monitors, weekly online content about lifestyle and mindfulness, and nurse check-in calls every two weeks for the first six weeks. The trial focuses on stress symptoms and related health outcomes in adults recently diagnosed with coronary heart disease.
Why it matters
Potential benefit: If successful, the program could offer an accessible online way to lower stress and support heart-healthy behaviors, potentially reducing the risk of further cardiac events.
How similar studies have gone: Previous trials of mindfulness and of eHealth cardiac rehabilitation have shown promising but mixed results, and combining mindfulness within an online CR program remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: People will be eligible for this study if they were: 1. diagnosed with CHD (within the past 6 months), 2. undergone conservative treatment, such as percutaneous coronary intervention (PCI) and/ or medication, 3. currently under stable medication regimen and discharged to home. 4. aged 18 years or older, 5. reported scores ranging from 3 (to some degree) to 5 (very much) scores on a single-item stress symptoms scale (Elo et al., 2003), 6. using a computer and/or smartphone to access the Internet at home, 7. and, read and speak Chinese. Exclusion Criteria: 1. diagnosis of acute psychotic disease; 2. presence of a life-limiting condition; 3. prescribed contradictions to physical activity; and, 4. presence of hearing, visual, or ambulatory disorders
Where it's running
-
Tung Wah College
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Jingjing Su, PhD
- Email: jjsu@twc.edu.hk
- Phone: 852-37256115
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single vs. dual antiplatelet therapy after drug-coated balloon PCI in coronary disease
This trial tests whether a single antiplatelet drug after a drug-coated balloon PCI is as safe and effective as the usual two-drug approach in adults with coronary disease.
-
AI-driven prediction of non-target coronary lesion progression after PCI
This project will test an AI tool that uses clinical data, blood biomarkers, and coronary imaging to see if it can predict which adults treated with PCI are likely to have progression of non-target coronary lesions.
-
Closed-loop brain neurofeedback on the left prefrontal cortex to lower stress-related heart responses in people with coronary heart disease and anxiety.
This trial will test whether closed‑loop fNIRS neurofeedback aimed at the left dorsolateral prefrontal cortex can lower heart rate during a cold‑pain stress test in adults with stable coronary heart disease and anxiety.
-
Closed-loop neurofeedback targeting the right prefrontal cortex to improve heart regulation in people with coronary heart disease and anxiety
This trial will try real-time fNIRS neurofeedback aimed at the right dorsolateral prefrontal cortex to lower sympathetic heart activity and improve heart rate variability in right-handed adults with stable coronary heart disease and DSM-5 anxiety.
-
Community- or home-based exercise for adults with weakened heart or lungs
This test will see if an eight-week, community- or home-based exercise program can improve heart and lung function in adults 18–85 with reduced cardiopulmonary fitness.
-
Village-based program to manage chronic heart conditions in Qujiang older adults
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.